Tag:
follow-on biologics
Latest Headlines
Latest Headlines
Process complexity could be barrier to biosimilars
The healthcare reform bill gives the FDA the power to approve follow-on biologics through an abbreviated process similar to the one for small molecule drugs. However, the complexity of biologics
